Axillary lymph node accumulation on FDG-PET/CT after influenza vaccination

Annals of Nuclear Medicine

Volumn 26, Issue 3, 2012, Pages 248-252

  Shirone, Norihisa ^a   Shinkai, Takayuki ^b   Yamane, Tomohiko ^c   Uto, Fumiaki ^a   Yoshimura, Hitoshi ^a   Tamai, Hiroyuki ^a   Imai, Teruhiko ^d   Inoue, Makoto ^e   Kitano, Satoru ^f   Kichikawa, Kimihiko ^b   Hasegawa, Masatoshi ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^d Saiseikai Nara Hospital   (Japan)

^e Yamato Mental Medical Center   (Japan)

^f Nara Social Insurance Hospital   (Japan)

Author keywords

Cancer screening; False positive; FDG PET CT; Influenza vaccination

Indexed keywords

FLUORODEOXYGLUCOSE F 18; INFLUENZA VACCINE;

ADULT; ARTICLE; AXILLARY LYMPH NODE; CANCER SCREENING; CASE REPORT; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONSENSUS; DRUG ACCUMULATION; FALSE POSITIVE RESULT; FEMALE; HUMAN; INFLUENZA VACCINATION; LYMPHADENITIS; MALE; PRIORITY JOURNAL; SEASONAL INFLUENZA;

ADULT; ARTIFACTS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLUENZA, HUMAN; LYMPH NODES; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RETROSPECTIVE STUDIES; SEASONS; VACCINATION;

EID: 84862694160     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-011-0568-x     Document Type: Article

References (18)

1. Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med. 2000; 27:822-32.
2. Williams G, Joyce RM, Parker JA. False-positive axillary lymph node on FDG-PET/CT scan resulting from immunization. Clin Nucl Med. 2006;31:731-2.
3. Iyengar S, Chin B, Margolick JB, Sabundayo BP, Schwartz DH. Anatomical loci of HIV-associated immune activation and association with viraemia. Lancet. 2003;362:945-50.
4. Panagiotidis E, Exarhos D, Housianakou I, Bournazos A, Datseris I. FDG uptake in axillary lymph nodes after vaccination against pandemic (H1N1). Eur Radiol. 2010;20:1251-3.
5. Thomassen A, Lerberg Nielsen A, Gerke O, Johansen A, Petersen H. Duration of 18F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination. Eur J Nucl Med Mol Imaging. 2011;38:894-8.
6. Burger IA, Husmann L, Hany TF, Schmid DT, Schaefer NG. Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine. Clin Nucl Med. 2011;36:848-53.
7. Focosi D, Caracciolo F, Galimberti S, Papineschi F, Petrini M. False positive PET scanning caused by inactivated influenza virus vaccination during complete remission from anaplastic T-cell lymphoma. Ann Hematol. 2008;87:343-4.
8. Brown LE. The role of adjuvants in vaccines for seasonal and pandemic influenza. Vaccine. 2010;28:8043-5.
9. Minamimoto R, Senda M, Terauchi T, Jinnouchi S, Inoue T, Iinuma T, et al. Analysis of various malignant neoplasms detected by FDG-PET cancer screening program: based on a Japanese Nationwide Survey. Ann Nucl Med. 2011;25:45-54.
10. Minamimoto R, Senda M, Uno K, Jinnouchi S, Iinuma T, Ito K, et al. Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey. Ann Nucl Med. 2007;21:481-98.
11. Barrington SF, O'Doherty MJ. Limitations of PET for imaging lymphoma. Eur J Nucl Med Mol Imaging. 2003;30:S117-27.
12. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas, NCI Sponsored International Working Group. J Clin Oncol. 1999;17: 1244-53.
13. Kwee TC, Kwee RM, Nievelstein RA. Imaging in staging of malignant lymphoma: a systematic review. Blood. 2008;111: 504-16.
14. Shien T, Akashi-Tanaka S, Yoshida M, Hojo T, Iwamoto E, Miyakawa K, et al. Evaluation of axillary status in patients with breast cancer using thin-section CT. Int J Clin Oncol. 2008;13:314-9.
15. Hara M, Tanaka K, Hirota Y. Immune response to influenza vaccine in healthy adults and the elderly: association with nutritional status. Vaccine. 2005;23:1457-63.
16. Sagawa M, Kojimahara N, Otsuka N, Kimura M, Yamaguchi N. Immune response to influenza vaccine in the elderly: association with nutritional and physical status. Geriatr Gerontol Int. 2011;11: 63-8.
17. Ansaldi F, Zancolli M, Durando P, Montomoli E, Sticchi L, Del Giudice G, et al. Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates. Vaccine. 2010;28: 4123-9.
18. Roman F, Vaman T, Gerlach B, Markendorf A, Gillard P, Devaster JM. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial. Vaccine. 2010;28:1740-5.